男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

衰老關鍵蛋白1(FBLN1)多克隆抗體

Polyclonal Antibody to Fibulin 1 (FBLN1)

  • 衰老關鍵蛋白1(FBLN1)多克隆抗體產品包裝(模擬)
  • 衰老關鍵蛋白1(FBLN1)多克隆抗體產品包裝(模擬)
  • 衰老關鍵蛋白1(FBLN1)多克隆抗體IHC圖
  • PAC472Ra01.jpgWestern Blot; Sample: Human Placenta lysate Primary Ab: 0.2μg/ml Rabbit Anti-Rat FBLN1 Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • 衰老關鍵蛋白1(FBLN1)多克隆抗體Figure. Western Blot; Sample: Lane1: Rat Serum; Lane2: Rat Placenta Tissue.
  • Certificate通過ISO 9001、ISO 13485質量體系認證

特異性

該抗體是針對FBLN1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別FBLN1。

用法

Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.

儲存

經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。

贈品

相關產品

編號適用物種:Rattus norvegicus (Rat,大鼠)應用(僅供研究使用,不用于臨床診斷!)
RPC472Ra02衰老關鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC472Ra01衰老關鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC472Ra01衰老關鍵蛋白1(FBLN1)多克隆抗體WB
PAC472Ra02衰老關鍵蛋白1(FBLN1)多克隆抗體WB; IHC
LAC472Ra71衰老關鍵蛋白1(FBLN1)多克隆抗體(生物素標記)WB
MAC472Ra22衰老關鍵蛋白1(FBLN1)單克隆抗體IHC; ICC/IF
MAC472Ra23衰老關鍵蛋白1(FBLN1)單克隆抗體IHC
MAC472Ra21衰老關鍵蛋白1(FBLN1)單克隆抗體IHC
LAC472Ra72衰老關鍵蛋白1(FBLN1)單克隆抗體(生物素標記)WB; IHC; ICC.
SEC472Ra衰老關鍵蛋白1(FBLN1)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMC472Ra衰老關鍵蛋白1(FBLN1)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
PSC472Ra01衰老關鍵蛋白1(FBLN1)抗體對ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSC472Ra01衰老關鍵蛋白1(FBLN1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志參考文獻
Clin Exp Metastasis.Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734]
Proteomics Clinical ApplicationsComparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509]
PROTEOMICS?-?Clinical?ApplicationsComparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients.[pubmed:26680509]
ENVIRONMENTAL RESEARCHExploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421]